CORC

在结果中检索

CORC

浏览/检索结果: 共22条，第1-10条 帮助

限定条件                    
已选(0)清除 条数/页：   排序方式：
A Global, Randomized, Placebo-Controlled, Phase 3 Study of Ibrutinib Plus Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (RCHOP) in Patients with Previously Untreated Non-Germinal Center B-Cell-like (GCB) Diffuse Large B-Cell Lymphoma (DLBCL) 会议论文
作者:  Duehrsen, Ulrich;  Younes, Anas;  Sehn, Laurie H.;  Johnson, Peter;  Zinzani, Pier Luigi
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
Gp130-mediated STAT3 Activation by S-propargyl-cysteine, an Endogenous Hydrogen Sulfide Initiator, Prevents Doxorubicin-induced Cardiotoxicity 会议论文
作者:  Wu, Jian;  Guo, Wei;  Wang, Zhi-Jun;  Zhu, Yi-Zhun
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05
Gp130-mediated STAT3 activation by S-propargyl-cysteine, an endogenous hydrogen sulfide initiator, prevents doxorubicin-induced cardiotoxicity 会议论文
作者:  Wu, Jian;  Wang, Zhijun;  Guo, Wei;  Zhu, Yizhun
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
Gp130-Mediated STAT3 Activation by S-Propargyl-Cysteine, an Endogenous Hydrogen Sulfide Initiator, Prevents Doxorubicin-Induced Cardiotoxicity 会议论文
作者:  Wu, Jian;  Zhu, Yi Zhun
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
Doxorubicin hydrochloride and curcumin loaded silk fibroin/hydroxypropylcellulose hydrogels for localized chemotherapy of cancer 会议论文
作者:  Cao, Han;  Yang, Yuhong;  Shao, Zhengzhong
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/19
Bortezomib (Btz) Dose Intensity Is the Strongest Predictor for Overall Survival (OS) in Mantle Cell Lymphoma (MCL) Patients (Pts) Not Considered for Transplantation, Receiving Frontline Btz Plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (VR-CAP) Therapy in the Phase 3 LYM-3002 Study 会议论文
作者:  Robak, Tadeusz;  Huang, Huiqiang;  Jin, Jie;  Zhu, Jun;  Liu, Ting
收藏  |  浏览/下载：9/0  |  提交时间：2019/12/19
PHASE 3 STUDY OF FRONTLINE RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, AND PREDNISONE PLUS VINCRISTINE (R-CHOP) OR BORTEZOMIB (VR-CAP) IN TRANSPLANTATION-UNSUITABLE MANTLE CELL LYMPHOMA (MCL) PATIENTS 会议论文
作者:  Robak, T.;  Huang, H.;  Jin, J.;  Zhu, J.;  Liu, T.
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/19
Elevated High Sensitivity Troponin T (HsTnT) during Front-Line Therapy with Cyclophosphamide, Doxorubicin, Vincristine and Prednisone plus /- Rituximab (CHOP plus /-R) or Cyclophosphamide, Epirubicin, Vincristine and Prednisone plus /- Rituximab (CEpOP plus /-R) Correlates with a Decline in Left Ventricular Ejection Fraction (LVEF) in Patients with Aggressive B-Cell Lymphoma: Results from a Randomized Prospective Clinical Trial NCT00854568 会议论文
作者:  Xue, Kai;  Gu, Juan J.;  Zhang, Qunling;  Liu, Xiaojian;  Wang, Jiachen
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/19
DevelopmentofbiodegradablepolymericimplantsofRGD-modifiedPEG-PAMAM-DOXconjugatesforlong-termintratumoralrelease 会议论文
作者:  Xiaofeng Zhang;  Ke Wang;  Yanyan Jiang
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/19
万方数据知识服务平台 会议论文
作者:  Yanzuo Chen;  Xianyi Sha;  Xiaoling Fang;  Gao Feng
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/19

©版权所有 ©2017 CSpace - Powered by CSpace